Ayr Strategies, an expanding vertically integrated, US multi-state cannabis operator, agreed to acquire Liberty Health Sciences, a manufacturer and distributor of medical cannabis, for c.$372m. "With the support from Ayr, Liberty dispensary openings across the state will accelerate and product expansion will be enhanced. Shareholders will benefit not only from the strong growth in the Florida market, but also from the growth in other key states. Our employees will have exposure to new opportunities and career paths. We are delighted to become part of the AYR family of companies," George Gremse, Liberty Interim Chief Executive Officer and Director. On February 23, 2021, Liberty Health Sciences shareholders approved the acquisition.